If you have a full-time job and already feel overwhelmed by the mental load of tracking every detail, opt for simplicity over complexity
A 2025 network meta-analysis ranked nausea risk as follows: orforglipron (highest, relative risk 4.77), liraglutide (3.09), semaglutide (2.94), tirzepatide (2.89), exenatide (2.66), and cagrilintide (2.29)
The phase of a trial reveals what stage the drug is in to get approval for a specific condition
Any retatrutide for sale online today is likely counterfeit and unsafe
With seven additional Phase 3 readouts expected in 2026, retatrutide is emerging as a potential next-generation standard of care one that could fundamentally reshape the metabolic medicine landscape
SGLT2 inhibitor therapy may be resumed following recovery